Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Efficiency Harmed By Commissioner Confirmation Process – Friedman

Executive Summary

FDA would be more effective if the Senate were not required to confirm the commissioner post, former Acting Commissioner Michael Friedman, MD, wrote in an editorial for the Dec. 20 issue of Science

You may also be interested in...

FDA Faster Approval Times For 2002 NMEs Aided By Resubmissions

The average total approval time for new molecular entities cleared by FDA in 2002 was 15.2 months, an analysis of new drug approvals shows

FDA Commissioner McClellan Sworn-In; First Focus Is Employee Morale

FDA Commissioner Mark McClellan, MD/PhD, is beginning his tenure at the agency by emphasizing employee morale and retention

FDA Bypass Budget, Separation From Ag Appropriations Suggested By Hatch

A proposal that would allow FDA to submit its budget request directly to the congressional panels responsible for funding the agency is being explored by Sens. Orrin Hatch (R-Utah) and Tom Harkin (D-Iowa)

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts